Pardis Azmoon

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2020-2022
Publications (10 Years): 3

Top Topics

Platelet Rich Plasma

Tyrosine Kinase

Top Venues

The Journal of biological chemistry

Nature communications

Journal of immunology (Baltimore, Md. : 1950)

Sapienza Università di Roma (MSC)

This page only lists publications with an associated author ORCID identifier.

Education History

Sapienza Università di Roma

Italy

MSC

Università degli Studi di Roma Tor Vergata

Italy

BSC

Publications

Davide Bernareggi, Qi Xie, Briana C Prager, Jiyoung Yun, Luisjesus S Cruz, Timothy V Pham, William Kim, Xiqing Li, Michael J Coffey, Cristina Zalfa, Pardis Azmoon, Huang Zhu, Pablo Tamayo, Jeremy N Rich, Dan S Kaufman
CHMP2A regulates tumor sensitivity to natural killer cell-mediated cytotoxicity. Nature communications 13 (1) (2022)
Elisabetta Mantuano, Pardis Azmoon, Michael A Banki, Christina J Sigurdson, Wendy M Campana, Steven L Gonias
A Soluble PrPC Derivative and Membrane-Anchored PrPC in Extracellular Vesicles Attenuate Innate Immunity by Engaging the NMDA-R/LRP1 Receptor Complex. Journal of immunology (Baltimore, Md. : 1950) (2021)
Elisabetta Mantuano, Pardis Azmoon, Michael A Banki, Michael S Lam, Christina J Sigurdson, Steven L Gonias
A soluble derivative of PrPC activates cell-signaling and regulates cell physiology through LRP1 and the NMDA receptor. The Journal of biological chemistry 295 (41) (2020)